Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population

Journal of Endourology

Volumn 22, Issue 2, 2008, Pages 369-375

  Walz, Jochen ^a,b,c   Suardi, Nazareno ^a,c,d   Hutterer, Georg C ^a,c,e   Perrotte, Paul ^c   Gallina, Andrea ^a,d   Bénard, Francois ^c   Valiquette, Luc ^c   McCormack, Michael ^c   Graefen, Markus ^b   Montorsi, Francesco ^d   Karakiewicz, Pierre I ^a,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; GERIATRIC PATIENT; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LINEAR REGRESSION ANALYSIS; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; URINARY FREQUENCY; URINARY TRACT OBSTRUCTION;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; URETHRAL OBSTRUCTION;

EID: 39749102939     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2007.0135     Document Type: Article

References (28)

1. Burke JP, Jacobson DJ, McGree ME, Roberts RO, Girman CJ, Lieber MM, Jacobsen SJ. Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota. Urology 2006;67:22-25.
2. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM. The prevalence of prostatism: A population-based survey of urinary symptoms. J Urol 1993;150:85-89.
3. Sagnier PP, MacFarlane G, Teillac P, Botto H, Richard F, Boyle P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community. J Urol 1995;153:669-673.
4. Berges RR, Pientka L. Management of the BPH syndrome in Germany: Who is treated and how? Eur Urol 1999;36 (suppl 3):21-27.
5. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: The multinational survey of the aging male (MSAM-7). Eur Urol 2003;44:637-649.
6. Andersson SO, Rashidkhani B, Karlberg L, Wolk A, Johansson JE. Prevalence of lower urinary tract symptoms in men aged 45-79 years: A population-based study of 40 000 Swedish men. BJU Int 2004;94:327-331.
7. Sarma AV, McLaughlin JC, Jacobsen SJ, et al. Longitudinal changes in lower urinary tract symptoms among a cohort of black American men: The Flint Men's Health Study. Urology 2004;64:959-965.
8. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Urology 2003;61:37-49.
9. Masters JG, Rice ML. Improvement in urinary symptoms after radical prostatectomy: A prospective evaluation of flow rates and symptom scores. BJU Int 2003;91:795-797.
10. Schwartz EJ, Lepor H. Radical retropubic prostatectomy reduces symptom scores and improves quality of life in men with moderate and severe lower urinary tract symptoms. J Urol 1999;161:1185-1188.
11. Bhatnagar V, Stewart ST, Huynh V, Jorgensen G, Kaplan RM. Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment. Prostate Cancer Prostatic Dis 2006;9:136-146.
12. Litwin MS. Health related quality of life in older men without prostate cancer. J Urol 1999;161:1180-1184.
13. Karakiewicz PI, Aprikian AG, Bazinet M, Elhilali MM. Patient attitudes regarding treatment-related erectile dysfunction at time of early detection of prostate cancer. Urology 1997;50:704-709.
14. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-1557.
15. Nickel JC, Elhilali M, Vallancien G; ALF-ONE Study Group. Benign prostatic hyperplasia (BPH) and prostatitis: Prevalence of painful ejaculation in men with clinical BPH. BJU Int 2005;95:571-574.
16. Middleton RG. The management of clinically localized prostate cancer: Guidelines from the American Urological Association. CA Cancer J Clin 1996;46:249-253.
17. Aus G, Abbou CC, Bolla M, Heidenreich A, Schmid HP, van Poppel H, Wolff J, Zattoni F; European Association of Urology. EAU guidelines on prostate cancer. Eur Urol 2005;48:546-551.
18. Lepor H, Kaci L. The impact of open radical retropubic prostatectomy on continence and lower urinary tract symptoms: A prospective assessment using validated self-administered outcome instruments. J Urol 2004;171:1216-1219.
19. Kumar V, Toussi H, Marr C, Hough C, Javle P. The benefits of radical prostatectomy beyond cancer control in symptomatic men with prostate cancer. BJU Int 2004;93:507-509.
20. Tsui G, Gillan C, Pond G, Catton C, Crook J. Posttreatment complications of early-stage prostate cancer patients: Brachytherapy versus three-dimensional conformal radiation therapy. Cancer J 2005;11:122-132.
21. Yan Y, Carvalhal GF, Catalona WJ, Young JD. Primary treatment choices for men with clinically localized prostate carcinoma detected by screening. Cancer 2000;88:1122-1130.
22. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Med Care 1998;36:1002-1012.
23. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000;56:899-905.
24. Briganti A, Gallina A, Salonia A, Farina E, Zanni G, Rigatti P, Montorsi F. Reliability of classification of erectile function domain of the international index of erectile function in patients affected by localized prostate cancer who are candidates for radical prostatectomy. Urology 2005;66:1140-1141.
25. Reggio E, de Bessa J Jr, Junqueira RG, Timm O Jr, Sette MJ, Sansana V, Gomes CM. Correlation between lower urinary tract symptoms and erectile dysfunction in men presenting for prostate cancer screening. Int J Impot Res 2007;19:492-495.
26. Blaivas JG, Weiss JP, Jones M. The pathophysiology of lower urinary tract symptoms after brachytherapy for prostate cancer. BJU Int 2006;98:1233-1237.
27. Godley PA, Carpenter WR. Case-control prostate cancer screening studies should not exclude subjects with lower urinary tract symptoms. J Clin Epidemiol 2007;60:176-180.
28. Blanker MH, Groeneveld FP, Prins A, Bernsen RM, Bohnen AM, Bosch JL. Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: The Krimpen study of male urogenital tract problems and general health status. BJU Int 2000;85:665-671.